Antiretroviral therapy coverage for PMTCT in Uganda

Uganda: Antiretroviral therapy coverage for PMTCT was 100.0% in 2024. ◆ Volatile

Latest (2024)
100.0%
Change on year
up 1.0%
World rank
1st
of 84 countries
All-time high
100.0%
in 2013
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Uganda, 2000–2024

0204060801002000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 5 % of pregnant women living with HIV2004: 12 % of pregnant women living with HIV2005: 19 % of pregnant women living with HIV2006: 28 % of pregnant women living with HIV2007: 36 % of pregnant women living with HIV2008: 56 % of pregnant women living with HIV2009: 62 % of pregnant women living with HIV2010: 37 % of pregnant women living with HIV2011: 62 % of pregnant women living with HIV2012: 99 % of pregnant women living with HIV2013: 100 % of pregnant women living with HIV2014: 100 % of pregnant women living with HIV2015: 100 % of pregnant women living with HIV2016: 100 % of pregnant women living with HIV2017: 100 % of pregnant women living with HIV2018: 100 % of pregnant women living with HIV2019: 100 % of pregnant women living with HIV2020: 100 % of pregnant women living with HIV2021: 100 % of pregnant women living with HIV2022: 95 % of pregnant women living with HIV2023: 99 % of pregnant women living with HIV2024: 100 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

The most recent figure for antiretroviral therapy coverage for pmtct in Uganda is 100.0%, measured in 2024. That is the highest value across all 25 years on record.

The figure is up 1.0% on the previous year and unchanged over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Uganda peaked at 100.0% in 2013 and was at its lowest, 0.0%, in 2000.

Uganda ranks 1st of 84 countries on this measure, in the top 10%.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Uganda, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Uganda, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 5.0%
2004 12.0% +140.0%
2005 19.0% +58.3%
2006 28.0% +47.4%
2007 36.0% +28.6%
2008 56.0% +55.6%
2009 62.0% +10.7%
2010 37.0% -40.3%
2011 62.0% +67.6%
2012 99.0% +59.7%
2013 100.0% +1.0%
2014 100.0% +0.0%
2015 100.0% +0.0%
2016 100.0% +0.0%
2017 100.0% +0.0%
2018 100.0% +0.0%
2019 100.0% +0.0%
2020 100.0% +0.0%
2021 100.0% +0.0%
2022 95.0% -5.0%
2023 99.0% +4.2%
2024 100.0% +1.0%

Uganda compared with similar countries

  • Uganda's 100.0% is above the median for low income countries, which is 73.0%, 1.4× the median. (22 countries reporting)
  • Uganda's 100.0% is above the median for Sub-Saharan Africa, which is 82.0%, 1.2× the median. (41 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Uganda changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2004 +140.0% 5.0% 12.0%
2011 +67.6% 37.0% 62.0%
2012 +59.7% 62.0% 99.0%
2005 +58.3% 12.0% 19.0%
2008 +55.6% 36.0% 56.0%
2006 +47.4% 19.0% 28.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 21.8% 0.0% 62.0% 10
2010s 89.8% 37.0% 100.0% 10
2020s 98.8% 95.0% 100.0% 5

Countries ranked near Uganda

  1. 1 Botswana 100.0% compare
  2. 1 Eswatini 100.0% compare
  3. 1 Ireland 100.0% compare

See the full ranking of 99 places →

More health data for Uganda

All data for Uganda →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Uganda?
Antiretroviral therapy coverage for pmtct in Uganda was 100.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Uganda?
The highest recorded value was 100.0% in 2013.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Uganda?
The lowest recorded value was 0.0% in 2000.
How does Uganda rank for antiretroviral therapy coverage for pmtct?
Uganda ranks 1st out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Uganda?
Over the last ten years it is unchanged. The long-run trend across the full record is volatile.
Where does this Uganda data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Uganda. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 17 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/uganda/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/uganda/">Antiretroviral therapy coverage for PMTCT in Uganda</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).